Suppr超能文献

小儿心脏移植排斥反应的低强度活检监测结果

Outcomes of low-intensity biopsy surveillance for rejection in paediatric cardiac transplantation.

作者信息

Evers Patrick D, Jorgensen Neal, Hong Borah, Albers Erin, Kemna Mariska, Friedland-Little Josh, Boucek Robert J, Law Yuk

机构信息

The Heart Institute, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, USA.

Division of Cardiology, Department of Pediatrics, University of Washington School of Medicine and Seattle Children's Hospital, Seattle, WA, USA.

出版信息

Cardiol Young. 2019 Jul;29(7):910-916. doi: 10.1017/S1047951119001112. Epub 2019 Jun 17.

Abstract

BACKGROUND

Significant inter-centre variability in the intensity of endomyocardial biopsy surveillance for rejection following paediatric cardiac transplantation has been reported. Our aim was to determine if low-intensity biopsy surveillance with two scheduled biopsies in the first year would produce outcomes similar to published registry outcomes.

METHODS

A retrospective study of paediatric recipients transplanted between 2008 and 2014 using a low-intensity biopsy protocol consisting of two surveillance biopsies at 3 and 12-13 months in the first post-transplant year, then annually thereafter. Additional biopsies were performed based on echocardiographic and clinical surveillance. Excluded were recipients that were re-transplanted or multi-organ transplanted or were followed at another institution.

RESULTS

A total of 81 recipients in the first 13 months after transplant underwent an average of 2 (SD ± 1.3) biopsies, 24 ± 6.8 echocardiograms, and 17 ± 4.4 clinic visits per recipient. During the 13-month period, 19 recipients had 24 treated rejection episodes, with the first at an average of 2.8 months post-transplant. The 3-, 12-, 36-, and 60-month conditional on discharge graft survival were 100%, 98.8%, 98.8%, and 90.4%, respectively, comparable to reported figures in major paediatric registries. At a mean follow-up of 4.7 ± 2.1 years, four patients (4.9%) developed cardiac allograft vasculopathy, three (3.7%) developed a malignancy, and seven (8.6%) suffered graft loss.

CONCLUSION

Rejection surveillance with a low-intensity biopsy protocol demonstrated similar intermediate-term outcomes and safety measures as international registries up to 5 years post-transplant.

摘要

背景

据报道,小儿心脏移植术后心内膜心肌活检监测排斥反应的强度在各中心之间存在显著差异。我们的目的是确定在第一年进行两次定期活检的低强度活检监测是否会产生与已发表的登记结果相似的结果。

方法

对2008年至2014年间接受移植的小儿受者进行回顾性研究,采用低强度活检方案,即在移植后的第一年3个月和12 - 13个月进行两次监测活检,此后每年进行一次。根据超声心动图和临床监测进行额外的活检。排除再次移植、多器官移植或在其他机构随访的受者。

结果

共有81名受者在移植后的前13个月内平均每人接受了2次(标准差±1.3)活检、24±6.8次超声心动图检查和17±4.4次门诊就诊。在这13个月期间,19名受者发生了24次治疗的排斥反应,首次发生时间平均为移植后2.8个月。出院后3个月、12个月、36个月和60个月的移植物生存率分别为100%、98.8%、98.8%和90.4%,与主要小儿登记处报告的数字相当。平均随访4.7±2.1年,4名患者(4.9%)发生心脏移植物血管病变,3名(3.7%)发生恶性肿瘤,7名(8.6%)发生移植物丢失。

结论

低强度活检方案的排斥反应监测在移植后5年内显示出与国际登记处相似的中期结果和安全措施。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验